Parallax Health Sciences Form 3 PARALLAX HEALTH SCIENCES / NATHANIEL T BRADLEY ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

BRADLEY NATHANIEL T

(Last) (First) (Middle)

1327 OCEAN AVENUE SUITE B

(Street)

SANTA MONICA CA 90401

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/04/2018

3. Issuer Name and Ticker or Trading Symbol
PARALLAX HEALTH SCIENCES, INC. [ PRLX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
Chief Technology Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
COMMON STOCK(1)	1,000,000	I	By Bradley Bros LLC
COMMON STOCK(2)	1,228,346	I	By Bradley Bros LLC
COMMON STOCK(3)	3,000,000	I	By Bradley Bros LLC

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
STOCK OPTIONS(1)	08/31/2017	08/31/2020	COMMON STOCK	200,000	0.1	D
STOCK OPTIONS(1)	08/31/2017	08/31/2020	COMMON STOCK	125,000	0.15	D
STOCK OPTIONS(1)	08/31/2017	08/31/2020	COMMON STOCK	100,000	0.25	D
STOCK OPTIONS(3)	08/01/2017	08/01/2022	COMMON STOCK	250,000	0.25	D
STOCK OPTIONS(3)	08/01/2018	08/01/2022	COMMON STOCK	250,000	0.25	D
STOCK OPTIONS(3)	08/01/2019	08/01/2022	COMMON STOCK	250,000	0.25	D
STOCK OPTIONS(3)	08/01/2020	08/01/2022	COMMON STOCK	250,000	0.25	D

Explanation of Responses:

1. Pursuant to Purchase Agreement with QOLPOM, Inc. dated 08/31/2016

2. Pursuant to conversion of debt dated 03/16/2017

3. Pursuant to Employment Agreement dated 08/01/2017

	NATHANIEL T BRADLEY	10/12/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.